Australian Patent Application

Combinations of linagliptin and metformin

Source-linked patent metadata for Combinations of linagliptin and metformin, including priority, record stage and longevity-topic connections.

Australian application snapshot

Patent application record

This privacy-minimal view describes one official Australian patent application record. It is not presented as a complete worldwide patent family.

Application number
AU2023201872
Earliest priority
June 10, 2016
Application date
March 27, 2023
Source record
1
Patent offices
1
Patent-to-Evidence Translation Map

What is happening in the same scientific field?

These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.

Organizations

Why names are absent

This feed intentionally excludes party names and contact details to minimise personal data. Open the official record when a name is consequential.

Longevity context

Topics connected by metadata

Metformin82% metadata match
Technical classification

How the patent office classifies this invention

A61K31/155 · A61K31/522 · A61K45/06 · A61K9/00

Verify in the original patent source →